

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 6.31416627 |
| 2 | chaperone-mediated protein transport (GO:0072321) | 6.00716823 |
| 3 | protein complex biogenesis (GO:0070271) | 5.73832304 |
| 4 | ribosomal small subunit biogenesis (GO:0042274) | 5.34100622 |
| 5 | mitochondrial respiratory chain complex assembly (GO:0033108) | 5.31144817 |
| 6 | mitochondrial respiratory chain complex I assembly (GO:0032981) | 5.09618520 |
| 7 | NADH dehydrogenase complex assembly (GO:0010257) | 5.09618520 |
| 8 | mitochondrial respiratory chain complex I biogenesis (GO:0097031) | 5.09618520 |
| 9 | viral transcription (GO:0019083) | 5.06821764 |
| 10 | neutrophil activation involved in immune response (GO:0002283) | 4.95019822 |
| 11 | hydrogen ion transmembrane transport (GO:1902600) | 4.81829652 |
| 12 | translational termination (GO:0006415) | 4.79580846 |
| 13 | ribosomal small subunit assembly (GO:0000028) | 4.72431593 |
| 14 | ATP biosynthetic process (GO:0006754) | 4.42405189 |
| 15 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 4.35812186 |
| 16 | cotranslational protein targeting to membrane (GO:0006613) | 4.33437252 |
| 17 | protein targeting to ER (GO:0045047) | 4.30408974 |
| 18 | regulation of mitochondrial translation (GO:0070129) | 4.30053831 |
| 19 | proton transport (GO:0015992) | 4.22129313 |
| 20 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 4.19542735 |
| 21 | termination of RNA polymerase III transcription (GO:0006386) | 4.19542735 |
| 22 | purine nucleoside triphosphate biosynthetic process (GO:0009145) | 4.17403034 |
| 23 | hydrogen transport (GO:0006818) | 4.15160268 |
| 24 | purine ribonucleoside triphosphate biosynthetic process (GO:0009206) | 4.11954119 |
| 25 | protein localization to endoplasmic reticulum (GO:0070972) | 4.09752917 |
| 26 | cytochrome complex assembly (GO:0017004) | 4.06647890 |
| 27 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 4.06133306 |
| 28 | aldehyde catabolic process (GO:0046185) | 4.05134014 |
| 29 | inner mitochondrial membrane organization (GO:0007007) | 3.94072418 |
| 30 | respiratory chain complex IV assembly (GO:0008535) | 3.91478934 |
| 31 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.86950279 |
| 32 | viral life cycle (GO:0019058) | 3.86104458 |
| 33 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.85236791 |
| 34 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.83116579 |
| 35 | ATP synthesis coupled proton transport (GO:0015986) | 3.83116579 |
| 36 | translational elongation (GO:0006414) | 3.82886236 |
| 37 | platelet dense granule organization (GO:0060155) | 3.79193683 |
| 38 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.73055668 |
| 39 | cellular protein complex disassembly (GO:0043624) | 3.63327403 |
| 40 | protein neddylation (GO:0045116) | 3.61039355 |
| 41 | protein targeting to mitochondrion (GO:0006626) | 3.58256072 |
| 42 | ribonucleoside triphosphate biosynthetic process (GO:0009201) | 3.58241016 |
| 43 | establishment of protein localization to mitochondrion (GO:0072655) | 3.56496164 |
| 44 | water-soluble vitamin biosynthetic process (GO:0042364) | 3.55854098 |
| 45 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.47944312 |
| 46 | superoxide anion generation (GO:0042554) | 3.47153887 |
| 47 | protein localization to mitochondrion (GO:0070585) | 3.46507995 |
| 48 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.45820239 |
| 49 | monocyte chemotaxis (GO:0002548) | 3.45405042 |
| 50 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.41076099 |
| 51 | negative regulation of ligase activity (GO:0051352) | 3.41076099 |
| 52 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.38053563 |
| 53 | respiratory burst (GO:0045730) | 3.37903027 |
| 54 | granulocyte activation (GO:0036230) | 3.33872459 |
| 55 | response to peptidoglycan (GO:0032494) | 3.33748790 |
| 56 | rRNA modification (GO:0000154) | 3.32335297 |
| 57 | sequestering of actin monomers (GO:0042989) | 3.28990142 |
| 58 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 3.28742020 |
| 59 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 3.28117932 |
| 60 | intracellular protein transmembrane import (GO:0044743) | 3.27373748 |
| 61 | cellular component biogenesis (GO:0044085) | 3.26831864 |
| 62 | eosinophil chemotaxis (GO:0048245) | 3.25627103 |
| 63 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.24273958 |
| 64 | nucleoside triphosphate biosynthetic process (GO:0009142) | 3.23658722 |
| 65 | neutrophil activation (GO:0042119) | 3.21648244 |
| 66 | mitochondrial transport (GO:0006839) | 3.21017411 |
| 67 | maturation of SSU-rRNA (GO:0030490) | 3.19864969 |
| 68 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 3.18538027 |
| 69 | respiratory electron transport chain (GO:0022904) | 3.16719859 |
| 70 | response to interferon-beta (GO:0035456) | 3.11640224 |
| 71 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 3.11012843 |
| 72 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 3.10386324 |
| 73 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 3.10352734 |
| 74 | ATP hydrolysis coupled proton transport (GO:0015991) | 3.10352734 |
| 75 | translational initiation (GO:0006413) | 3.09996981 |
| 76 | nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291) | 3.08324573 |
| 77 | cullin deneddylation (GO:0010388) | 3.07804687 |
| 78 | electron transport chain (GO:0022900) | 3.07782076 |
| 79 | reactive oxygen species biosynthetic process (GO:1903409) | 3.07485452 |
| 80 | protein-cofactor linkage (GO:0018065) | 3.06891333 |
| 81 | ribosomal large subunit biogenesis (GO:0042273) | 3.06639522 |
| 82 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 3.04579492 |
| 83 | proteasome assembly (GO:0043248) | 2.99565575 |
| 84 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.96732329 |
| 85 | mRNA catabolic process (GO:0006402) | 2.94590346 |
| 86 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay | 2.92323312 |
| 87 | establishment of protein localization to membrane (GO:0090150) | 2.91699356 |
| 88 | eosinophil migration (GO:0072677) | 2.91639015 |
| 89 | cellular response to zinc ion (GO:0071294) | 2.91587126 |
| 90 | protein targeting to membrane (GO:0006612) | 2.90807072 |
| 91 | regulation of oxidative phosphorylation (GO:0002082) | 2.90739734 |
| 92 | protein targeting (GO:0006605) | 2.88643581 |
| 93 | purine ribonucleoside monophosphate biosynthetic process (GO:0009168) | 2.88205266 |
| 94 | purine nucleoside monophosphate biosynthetic process (GO:0009127) | 2.88205266 |
| 95 | regulation of activation of Janus kinase activity (GO:0010533) | 2.87636610 |
| 96 | 7-methylguanosine mRNA capping (GO:0006370) | 2.87467180 |
| 97 | mannosylation (GO:0097502) | 2.84202538 |
| 98 | protein deneddylation (GO:0000338) | 2.82669015 |
| 99 | protein complex disassembly (GO:0043241) | 2.82258177 |
| 100 | positive regulation of ligase activity (GO:0051351) | 2.80518125 |
| 101 | oxidative phosphorylation (GO:0006119) | 2.80228297 |
| 102 | RNA capping (GO:0036260) | 2.78822068 |
| 103 | 7-methylguanosine RNA capping (GO:0009452) | 2.78822068 |
| 104 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.78277430 |
| 105 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.77324280 |
| 106 | lipoxygenase pathway (GO:0019372) | 2.76900664 |
| 107 | cellular response to interferon-beta (GO:0035458) | 2.75398103 |
| 108 | translation (GO:0006412) | 2.75256147 |
| 109 | removal of superoxide radicals (GO:0019430) | 2.71597314 |
| 110 | cellular response to superoxide (GO:0071451) | 2.71597314 |
| 111 | cellular response to oxygen radical (GO:0071450) | 2.71597314 |
| 112 | regulation of monocyte chemotaxis (GO:0090025) | 2.71330861 |
| 113 | positive regulation of antigen processing and presentation (GO:0002579) | 2.69149200 |
| 114 | positive regulation of lymphocyte migration (GO:2000403) | 2.66642680 |
| 115 | antigen processing and presentation of peptide antigen via MHC class I (GO:0002474) | 2.65260379 |
| 116 | amyloid precursor protein catabolic process (GO:0042987) | 2.63098530 |
| 117 | macromolecular complex disassembly (GO:0032984) | 2.62528012 |
| 118 | regulation of antigen processing and presentation (GO:0002577) | 2.57833309 |
| 119 | regulation of metalloenzyme activity (GO:0048552) | 2.56380474 |
| 120 | GTP biosynthetic process (GO:0006183) | 2.55636550 |
| 121 | positive regulation of T cell migration (GO:2000406) | 2.55469086 |
| 122 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.55066737 |
| 123 | immunoglobulin mediated immune response (GO:0016064) | 2.53698213 |
| 124 | regulation of cellular amino acid metabolic process (GO:0006521) | 2.53315011 |
| 125 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.53148517 |
| 126 | regulation of T-helper 1 cell differentiation (GO:0045625) | 2.52928080 |
| 127 | regulation of hypersensitivity (GO:0002883) | 2.52779313 |
| 128 | hydrogen peroxide metabolic process (GO:0042743) | 2.52230693 |
| 129 | response to muramyl dipeptide (GO:0032495) | 2.51856323 |
| 130 | regulation of T cell migration (GO:2000404) | 2.51829924 |
| 131 | positive regulation of interferon-alpha production (GO:0032727) | 2.48926835 |
| 132 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.48907830 |
| 133 | natural killer cell mediated immunity (GO:0002228) | 2.48907830 |
| 134 | fatty acid elongation (GO:0030497) | 2.48184294 |
| 135 | positive regulation of type 2 immune response (GO:0002830) | 2.47001226 |
| 136 | myeloid cell homeostasis (GO:0002262) | 2.44176058 |
| 137 | prostaglandin biosynthetic process (GO:0001516) | 2.44006405 |
| 138 | prostanoid biosynthetic process (GO:0046457) | 2.44006405 |
| 139 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.43911186 |
| 140 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.43743020 |
| 141 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.43743020 |
| 142 | L-ascorbic acid metabolic process (GO:0019852) | 2.43684253 |
| 143 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.42963717 |
| 144 | regulation of immunoglobulin secretion (GO:0051023) | 2.42482591 |
| 145 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.41825963 |
| 146 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.41825963 |
| 147 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.41825963 |
| 148 | regulation of mononuclear cell migration (GO:0071675) | 2.38473162 |
| 149 | phagosome maturation (GO:0090382) | 2.34854780 |
| 150 | microglial cell activation (GO:0001774) | 2.33037032 |
| 151 | regulation of interferon-alpha production (GO:0032647) | 2.32825468 |
| 152 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.29024236 |
| 153 | regulation of lymphocyte migration (GO:2000401) | 2.28429151 |
| 154 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.26285886 |
| 155 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.26285886 |
| 156 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.25437806 |
| 157 | modulation by symbiont of host immune response (GO:0052553) | 2.25024161 |
| 158 | modulation by symbiont of host defense response (GO:0052031) | 2.25024161 |
| 159 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.25024161 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 5.28776797 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 5.09144102 |
| 3 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.95792949 |
| 4 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 4.47621356 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.07537182 |
| 6 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 3.20556241 |
| 7 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 3.09590085 |
| 8 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.93671079 |
| 9 | * IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.80920268 |
| 10 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.80681410 |
| 11 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.60945096 |
| 12 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.58676842 |
| 13 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.53933577 |
| 14 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.43094494 |
| 15 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 2.33615485 |
| 16 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.30885690 |
| 17 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.22560969 |
| 18 | FOXP3_21729870_ChIP-Seq_TREG_Human | 2.13925096 |
| 19 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.12941988 |
| 20 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.09984092 |
| 21 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.04749720 |
| 22 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.02168010 |
| 23 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.97690058 |
| 24 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.93711261 |
| 25 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.93530047 |
| 26 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.90390856 |
| 27 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.89501658 |
| 28 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.89070453 |
| 29 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.86636428 |
| 30 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.80803341 |
| 31 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.80026208 |
| 32 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.79314140 |
| 33 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.78753981 |
| 34 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.78298952 |
| 35 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.77668432 |
| 36 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.76891157 |
| 37 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.75422203 |
| 38 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.75422203 |
| 39 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.75422203 |
| 40 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.74054662 |
| 41 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.73561244 |
| 42 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.73266463 |
| 43 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.72659145 |
| 44 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.70687250 |
| 45 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 1.69305069 |
| 46 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.69055030 |
| 47 | MYC_18940864_ChIP-ChIP_HL60_Human | 1.65451607 |
| 48 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.65272658 |
| 49 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.65090710 |
| 50 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.56340865 |
| 51 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.53346323 |
| 52 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.52069514 |
| 53 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.51487683 |
| 54 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.44655843 |
| 55 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43663941 |
| 56 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.43507532 |
| 57 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.42885808 |
| 58 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.39395548 |
| 59 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.38137102 |
| 60 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.36410124 |
| 61 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.36313566 |
| 62 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.34479528 |
| 63 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.34403943 |
| 64 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.34349984 |
| 65 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.32343637 |
| 66 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.30714213 |
| 67 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.30339452 |
| 68 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.28949504 |
| 69 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.27432091 |
| 70 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.25557691 |
| 71 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.23954191 |
| 72 | PAX6_23342162_ChIP-ChIP_BETA-FORBRAIN-LENS_Mouse | 1.23624741 |
| 73 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.22954823 |
| 74 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.22632724 |
| 75 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.20907153 |
| 76 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.20030247 |
| 77 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.18915704 |
| 78 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.18565624 |
| 79 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.18525218 |
| 80 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.18338484 |
| 81 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.17929801 |
| 82 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.15845050 |
| 83 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.13879284 |
| 84 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.12511412 |
| 85 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.12335282 |
| 86 | * ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.12333236 |
| 87 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.10188903 |
| 88 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.10061509 |
| 89 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.05498551 |
| 90 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.04817953 |
| 91 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03223940 |
| 92 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.02689513 |
| 93 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.02394636 |
| 94 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.02169077 |
| 95 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.99970498 |
| 96 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.99858666 |
| 97 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 0.99851796 |
| 98 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.98235658 |
| 99 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.97788093 |
| 100 | ERG_20517297_ChIP-Seq_VCAP_Human | 0.97725236 |
| 101 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.97686573 |
| 102 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 0.97626737 |
| 103 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.97565109 |
| 104 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 0.96789988 |
| 105 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 0.96079559 |
| 106 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.96055137 |
| 107 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.96012513 |
| 108 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.95826677 |
| 109 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.95419433 |
| 110 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.95104543 |
| 111 | TTF2_22483619_ChIP-Seq_HELA_Human | 0.94171890 |
| 112 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.92205934 |
| 113 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.92205934 |
| 114 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.91876251 |
| 115 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.91390088 |
| 116 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.90905256 |
| 117 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.90250016 |
| 118 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.90076353 |
| 119 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.90067392 |
| 120 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.90045823 |
| 121 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.89858598 |
| 122 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.89790332 |
| 123 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.89568863 |
| 124 | VDR_22108803_ChIP-Seq_LS180_Human | 0.89529492 |
| 125 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 0.89238751 |
| 126 | SIN3B_21632747_ChIP-Seq_MESCs_Mouse | 0.88654335 |
| 127 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 0.88110093 |
| 128 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.87840140 |
| 129 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 0.87825358 |
| 130 | ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 0.85980098 |
| 131 | * CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 0.85390196 |
| 132 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.85242183 |
| 133 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.84931762 |
| 134 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.84417877 |
| 135 | TP53_22573176_ChIP-Seq_HFKS_Human | 0.83914969 |
| 136 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.83120796 |
| 137 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.80829097 |
| 138 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 0.79802410 |
| 139 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.79457105 |
| 140 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.77577722 |
| 141 | * FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.75629648 |
| 142 | * FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.75629648 |
| 143 | * SOX17_20123909_ChIP-Seq_XEN_Mouse | 0.74665492 |
| 144 | AR_20517297_ChIP-Seq_VCAP_Human | 0.74628112 |
| 145 | KDM5A_27292631_Chip-Seq_BREAST_Human | 0.73917202 |
| 146 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 0.73380177 |
| 147 | * FOXP1_21924763_ChIP-Seq_HESCs_Human | 0.73251774 |
| 148 | SOX2_16153702_ChIP-ChIP_HESCs_Human | 0.68166478 |
| 149 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.67147175 |
| 150 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 0.64866410 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 4.00406211 |
| 2 | MP0001835_abnormal_antigen_presentation | 3.85887105 |
| 3 | MP0009379_abnormal_foot_pigmentation | 3.83889957 |
| 4 | MP0002148_abnormal_hypersensitivity_rea | 3.72642881 |
| 5 | MP0003186_abnormal_redox_activity | 3.39840933 |
| 6 | MP0009785_altered_susceptibility_to | 3.28064634 |
| 7 | MP0003436_decreased_susceptibility_to | 3.14796488 |
| 8 | MP0003724_increased_susceptibility_to | 3.09556975 |
| 9 | MP0002938_white_spotting | 2.88111154 |
| 10 | MP0006082_CNS_inflammation | 2.70774048 |
| 11 | MP0003806_abnormal_nucleotide_metabolis | 2.46599407 |
| 12 | MP0005025_abnormal_response_to | 2.43428595 |
| 13 | MP0005000_abnormal_immune_tolerance | 2.43425413 |
| 14 | MP0002419_abnormal_innate_immunity | 2.37555450 |
| 15 | MP0010030_abnormal_orbit_morphology | 2.26827929 |
| 16 | MP0001853_heart_inflammation | 2.20840227 |
| 17 | MP0004381_abnormal_hair_follicle | 2.15657082 |
| 18 | MP0003136_yellow_coat_color | 2.13810326 |
| 19 | MP0002254_reproductive_system_inflammat | 2.11086168 |
| 20 | MP0005671_abnormal_response_to | 2.04832385 |
| 21 | MP0006036_abnormal_mitochondrial_physio | 2.03634024 |
| 22 | MP0002277_abnormal_respiratory_mucosa | 1.98516620 |
| 23 | MP0006072_abnormal_retinal_apoptosis | 1.97270866 |
| 24 | MP0000685_abnormal_immune_system | 1.96129315 |
| 25 | MP0001790_abnormal_immune_system | 1.93220987 |
| 26 | MP0005387_immune_system_phenotype | 1.93220987 |
| 27 | MP0009764_decreased_sensitivity_to | 1.90723280 |
| 28 | MP0002452_abnormal_antigen_presenting | 1.76759004 |
| 29 | MP0002723_abnormal_immune_serum | 1.73528967 |
| 30 | MP0001346_abnormal_lacrimal_gland | 1.72565274 |
| 31 | MP0004142_abnormal_muscle_tone | 1.71195605 |
| 32 | MP0002796_impaired_skin_barrier | 1.67964044 |
| 33 | MP0003011_delayed_dark_adaptation | 1.67368832 |
| 34 | MP0004782_abnormal_surfactant_physiolog | 1.59501927 |
| 35 | MP0002405_respiratory_system_inflammati | 1.58443401 |
| 36 | MP0002138_abnormal_hepatobiliary_system | 1.57320052 |
| 37 | MP0000372_irregular_coat_pigmentation | 1.56788195 |
| 38 | MP0001533_abnormal_skeleton_physiology | 1.56148802 |
| 39 | MP0003941_abnormal_skin_development | 1.55811457 |
| 40 | MP0001800_abnormal_humoral_immune | 1.52573487 |
| 41 | MP0002132_abnormal_respiratory_system | 1.49224115 |
| 42 | MP0001819_abnormal_immune_cell | 1.47756902 |
| 43 | MP0005451_abnormal_body_composition | 1.47286649 |
| 44 | MP0003195_calcinosis | 1.44254581 |
| 45 | MP0008469_abnormal_protein_level | 1.44226407 |
| 46 | MP0009840_abnormal_foam_cell | 1.44060422 |
| 47 | MP0002420_abnormal_adaptive_immunity | 1.43844173 |
| 48 | MP0009333_abnormal_splenocyte_physiolog | 1.43527158 |
| 49 | MP0002095_abnormal_skin_pigmentation | 1.43201850 |
| 50 | MP0003315_abnormal_perineum_morphology | 1.43095839 |
| 51 | MP0001542_abnormal_bone_strength | 1.42649234 |
| 52 | MP0005164_abnormal_response_to | 1.40392666 |
| 53 | MP0000343_altered_response_to | 1.39239669 |
| 54 | MP0001845_abnormal_inflammatory_respons | 1.38557043 |
| 55 | MP0006035_abnormal_mitochondrial_morpho | 1.36901529 |
| 56 | MP0008875_abnormal_xenobiotic_pharmacok | 1.35739589 |
| 57 | MP0004019_abnormal_vitamin_homeostasis | 1.33332628 |
| 58 | MP0009046_muscle_twitch | 1.31386955 |
| 59 | MP0005332_abnormal_amino_acid | 1.28612414 |
| 60 | MP0005365_abnormal_bile_salt | 1.28204548 |
| 61 | MP0006292_abnormal_olfactory_placode | 1.24443085 |
| 62 | MP0002163_abnormal_gland_morphology | 1.23439799 |
| 63 | MP0002090_abnormal_vision | 1.23274143 |
| 64 | MP0001529_abnormal_vocalization | 1.21435516 |
| 65 | MP0002006_tumorigenesis | 1.21157644 |
| 66 | MP0002653_abnormal_ependyma_morphology | 1.20164549 |
| 67 | MP0003453_abnormal_keratinocyte_physiol | 1.20006692 |
| 68 | MP0005084_abnormal_gallbladder_morpholo | 1.19932190 |
| 69 | MP0002736_abnormal_nociception_after | 1.18869627 |
| 70 | MP0002638_abnormal_pupillary_reflex | 1.17485072 |
| 71 | MP0005058_abnormal_lysosome_morphology | 1.17212634 |
| 72 | MP0002098_abnormal_vibrissa_morphology | 1.16160578 |
| 73 | MP0004742_abnormal_vestibular_system | 1.15941433 |
| 74 | MP0002102_abnormal_ear_morphology | 1.15386280 |
| 75 | MP0005464_abnormal_platelet_physiology | 1.15273993 |
| 76 | MP0003448_altered_tumor_morphology | 1.13587893 |
| 77 | MP0004947_skin_inflammation | 1.12989013 |
| 78 | MP0003191_abnormal_cellular_cholesterol | 1.12235748 |
| 79 | MP0005253_abnormal_eye_physiology | 1.11500849 |
| 80 | MP0005075_abnormal_melanosome_morpholog | 1.11098571 |
| 81 | MP0000858_altered_metastatic_potential | 1.10046816 |
| 82 | MP0001851_eye_inflammation | 1.09673866 |
| 83 | * MP0005408_hypopigmentation | 1.06950114 |
| 84 | MP0003880_abnormal_central_pattern | 1.06303811 |
| 85 | MP0003786_premature_aging | 1.03197202 |
| 86 | MP0010155_abnormal_intestine_physiology | 1.02876222 |
| 87 | MP0004883_abnormal_blood_vessel | 1.01884703 |
| 88 | MP0001984_abnormal_olfaction | 1.00933159 |
| 89 | MP0005171_absent_coat_pigmentation | 1.00901402 |
| 90 | MP0000358_abnormal_cell_content/ | 1.00599390 |
| 91 | MP0000371_diluted_coat_color | 0.98649085 |
| 92 | MP0005174_abnormal_tail_pigmentation | 0.96209737 |
| 93 | MP0005085_abnormal_gallbladder_physiolo | 0.95489909 |
| 94 | MP0005501_abnormal_skin_physiology | 0.95198640 |
| 95 | MP0009763_increased_sensitivity_to | 0.93733464 |
| 96 | MP0001324_abnormal_eye_pigmentation | 0.92426122 |
| 97 | MP0001905_abnormal_dopamine_level | 0.90468735 |
| 98 | MP0005310_abnormal_salivary_gland | 0.90416107 |
| 99 | MP0001216_abnormal_epidermal_layer | 0.88386253 |
| 100 | MP0000920_abnormal_myelination | 0.88345018 |
| 101 | MP0000716_abnormal_immune_system | 0.87675354 |
| 102 | * MP0002295_abnormal_pulmonary_circulatio | 0.86391424 |
| 103 | MP0005165_increased_susceptibility_to | 0.86008811 |
| 104 | MP0005083_abnormal_biliary_tract | 0.85872895 |
| 105 | MP0009745_abnormal_behavioral_response | 0.84186435 |
| 106 | MP0005390_skeleton_phenotype | 0.82194183 |
| 107 | MP0008058_abnormal_DNA_repair | 0.81702271 |
| 108 | MP0002136_abnormal_kidney_physiology | 0.81359229 |
| 109 | MP0009643_abnormal_urine_homeostasis | 0.80762814 |
| 110 | MP0002998_abnormal_bone_remodeling | 0.80753558 |
| 111 | MP0003075_altered_response_to | 0.79897604 |
| 112 | MP0002876_abnormal_thyroid_physiology | 0.79894735 |
| 113 | MP0002282_abnormal_trachea_morphology | 0.79656854 |
| 114 | MP0001764_abnormal_homeostasis | 0.79649003 |
| 115 | MP0002139_abnormal_hepatobiliary_system | 0.79243589 |
| 116 | MP0005551_abnormal_eye_electrophysiolog | 0.78544115 |
| 117 | MP0004510_myositis | 0.78199698 |
| 118 | MP0003123_paternal_imprinting | 0.78193337 |
| 119 | MP0008789_abnormal_olfactory_epithelium | 0.77164382 |
| 120 | MP0005410_abnormal_fertilization | 0.76516186 |
| 121 | MP0008260_abnormal_autophagy | 0.76256076 |
| 122 | MP0001879_abnormal_lymphatic_vessel | 0.76133487 |
| 123 | MP0001756_abnormal_urination | 0.76018246 |
| 124 | MP0002272_abnormal_nervous_system | 0.75596024 |
| 125 | MP0005360_urolithiasis | 0.74980080 |
| 126 | MP0002166_altered_tumor_susceptibility | 0.74612025 |
| 127 | MP0003303_peritoneal_inflammation | 0.74167656 |
| 128 | MP0005379_endocrine/exocrine_gland_phen | 0.73254317 |
| 129 | MP0003638_abnormal_response/metabolism_ | 0.72710642 |
| 130 | MP0005195_abnormal_posterior_eye | 0.72029747 |
| 131 | MP0010386_abnormal_urinary_bladder | 0.70685112 |
| 132 | MP0004133_heterotaxia | 0.70513716 |
| 133 | MP0009697_abnormal_copulation | 0.69821297 |
| 134 | MP0000249_abnormal_blood_vessel | 0.69724982 |
| 135 | MP0000647_abnormal_sebaceous_gland | 0.69355629 |
| 136 | MP0000026_abnormal_inner_ear | 0.69283050 |
| 137 | MP0008995_early_reproductive_senescence | 0.68913041 |
| 138 | MP0005167_abnormal_blood-brain_barrier | 0.68600814 |
| 139 | MP0002429_abnormal_blood_cell | 0.68568046 |
| 140 | MP0005409_darkened_coat_color | 0.68258789 |
| 141 | MP0003690_abnormal_glial_cell | 0.68038180 |
| 142 | MP0001919_abnormal_reproductive_system | 0.67924689 |
| 143 | MP0005275_abnormal_skin_tensile | 0.67796634 |
| 144 | MP0005376_homeostasis/metabolism_phenot | 0.67554772 |
| 145 | MP0006276_abnormal_autonomic_nervous | 0.66992192 |
| 146 | * MP0002064_seizures | 0.66402330 |
| 147 | MP0001485_abnormal_pinna_reflex | 0.63227754 |
| 148 | * MP0003718_maternal_effect | 0.62135901 |
| 149 | MP0005367_renal/urinary_system_phenotyp | 0.61651443 |
| 150 | MP0000516_abnormal_urinary_system | 0.61651443 |
| 151 | MP0005266_abnormal_metabolism | 0.60851457 |
| 152 | MP0001968_abnormal_touch/_nociception | 0.60383837 |
| 153 | MP0005646_abnormal_pituitary_gland | 0.60186818 |
| 154 | MP0005319_abnormal_enzyme/_coenzyme | 0.60106220 |
| 155 | MP0002693_abnormal_pancreas_physiology | 0.58981237 |
| 156 | MP0001727_abnormal_embryo_implantation | 0.58211141 |
| 157 | MP0001663_abnormal_digestive_system | 0.58075353 |
| 158 | MP0003938_abnormal_ear_development | 0.57838036 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 4.35595867 |
| 2 | Parakeratosis (HP:0001036) | 4.28626680 |
| 3 | Abnormality of cells of the erythroid lineage (HP:0012130) | 4.12721046 |
| 4 | Eczematoid dermatitis (HP:0000976) | 4.09045797 |
| 5 | Recurrent bacterial skin infections (HP:0005406) | 4.08512619 |
| 6 | Congenital nonbullous ichthyosiform erythroderma (HP:0007479) | 3.98616212 |
| 7 | Renal Fanconi syndrome (HP:0001994) | 3.70721696 |
| 8 | Increased hepatocellular lipid droplets (HP:0006565) | 3.65010665 |
| 9 | Reticulocytopenia (HP:0001896) | 3.58737396 |
| 10 | Exertional dyspnea (HP:0002875) | 3.56117165 |
| 11 | Abnormality of macrophages (HP:0004311) | 3.52887648 |
| 12 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.52670039 |
| 13 | Abnormal number of erythroid precursors (HP:0012131) | 3.50337225 |
| 14 | Vacuolated lymphocytes (HP:0001922) | 3.49704564 |
| 15 | Acute necrotizing encephalopathy (HP:0006965) | 3.40893007 |
| 16 | Congenital ichthyosiform erythroderma (HP:0007431) | 3.38373393 |
| 17 | Lactic acidosis (HP:0003128) | 3.34837720 |
| 18 | Mitochondrial inheritance (HP:0001427) | 3.29174736 |
| 19 | Lipid accumulation in hepatocytes (HP:0006561) | 3.26096858 |
| 20 | Abnormal hemoglobin (HP:0011902) | 3.22859625 |
| 21 | Generalized aminoaciduria (HP:0002909) | 3.19742307 |
| 22 | Optic disc pallor (HP:0000543) | 3.10655502 |
| 23 | Systemic lupus erythematosus (HP:0002725) | 3.09426952 |
| 24 | Macrocytic anemia (HP:0001972) | 3.07550065 |
| 25 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.98201180 |
| 26 | Axonal loss (HP:0003447) | 2.95331490 |
| 27 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.93314869 |
| 28 | Acute encephalopathy (HP:0006846) | 2.84984816 |
| 29 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.83376805 |
| 30 | 3-Methylglutaconic aciduria (HP:0003535) | 2.74995028 |
| 31 | Mediastinal lymphadenopathy (HP:0100721) | 2.72911959 |
| 32 | Increased IgM level (HP:0003496) | 2.72683827 |
| 33 | Lethargy (HP:0001254) | 2.71351706 |
| 34 | Progressive macrocephaly (HP:0004481) | 2.68339059 |
| 35 | Abnormality of renal resorption (HP:0011038) | 2.67284788 |
| 36 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 2.67211862 |
| 37 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.67002447 |
| 38 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.67002447 |
| 39 | Abnormality of glycolipid metabolism (HP:0010969) | 2.67002447 |
| 40 | Stenosis of the external auditory canal (HP:0000402) | 2.59922145 |
| 41 | Increased CSF lactate (HP:0002490) | 2.59826984 |
| 42 | Methylmalonic aciduria (HP:0012120) | 2.56979946 |
| 43 | Recurrent skin infections (HP:0001581) | 2.56924291 |
| 44 | Pallor (HP:0000980) | 2.56407380 |
| 45 | Abnormality of the axillary hair (HP:0100134) | 2.53619081 |
| 46 | Abnormality of secondary sexual hair (HP:0009888) | 2.53619081 |
| 47 | Hepatosplenomegaly (HP:0001433) | 2.51532395 |
| 48 | CNS demyelination (HP:0007305) | 2.49888625 |
| 49 | Prolonged neonatal jaundice (HP:0006579) | 2.47863174 |
| 50 | Hepatocellular necrosis (HP:0001404) | 2.47163735 |
| 51 | Type I transferrin isoform profile (HP:0003642) | 2.46524762 |
| 52 | Increased intramyocellular lipid droplets (HP:0012240) | 2.46449491 |
| 53 | Hepatic necrosis (HP:0002605) | 2.43825225 |
| 54 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.40431095 |
| 55 | Obstructive lung disease (HP:0006536) | 2.39958852 |
| 56 | Chronic obstructive pulmonary disease (HP:0006510) | 2.39958852 |
| 57 | Methylmalonic acidemia (HP:0002912) | 2.36341659 |
| 58 | Degeneration of anterior horn cells (HP:0002398) | 2.35998490 |
| 59 | Abnormality of the anterior horn cell (HP:0006802) | 2.35998490 |
| 60 | X-linked dominant inheritance (HP:0001423) | 2.31083568 |
| 61 | Glycosuria (HP:0003076) | 2.28166230 |
| 62 | Abnormality of urine glucose concentration (HP:0011016) | 2.28166230 |
| 63 | Cerebral edema (HP:0002181) | 2.25907226 |
| 64 | Limb dystonia (HP:0002451) | 2.25855708 |
| 65 | Oral leukoplakia (HP:0002745) | 2.24778364 |
| 66 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.24229440 |
| 67 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.24229440 |
| 68 | Emotional lability (HP:0000712) | 2.22684003 |
| 69 | Congenital, generalized hypertrichosis (HP:0004540) | 2.20315345 |
| 70 | Stomatitis (HP:0010280) | 2.20261549 |
| 71 | Erythroderma (HP:0001019) | 2.19058871 |
| 72 | Poor head control (HP:0002421) | 2.18489329 |
| 73 | Abnormality of midbrain morphology (HP:0002418) | 2.13987565 |
| 74 | Molar tooth sign on MRI (HP:0002419) | 2.13987565 |
| 75 | Increased muscle lipid content (HP:0009058) | 2.10945614 |
| 76 | Pancreatic cysts (HP:0001737) | 2.10213648 |
| 77 | Respiratory difficulties (HP:0002880) | 2.10085816 |
| 78 | Nausea (HP:0002018) | 2.09923051 |
| 79 | Petechiae (HP:0000967) | 2.09049533 |
| 80 | Abnormality of methionine metabolism (HP:0010901) | 2.08381892 |
| 81 | Prolonged partial thromboplastin time (HP:0003645) | 2.07770080 |
| 82 | Thick nail (HP:0001805) | 2.07613791 |
| 83 | Amniotic constriction ring (HP:0009775) | 2.03267625 |
| 84 | Abnormality of placental membranes (HP:0011409) | 2.03267625 |
| 85 | Vasculitis (HP:0002633) | 2.01811534 |
| 86 | Purpura (HP:0000979) | 2.01156083 |
| 87 | Urticaria (HP:0001025) | 2.00993293 |
| 88 | Gingivitis (HP:0000230) | 2.00827509 |
| 89 | Blindness (HP:0000618) | 2.00410107 |
| 90 | Hyperphosphaturia (HP:0003109) | 1.99759688 |
| 91 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.98903157 |
| 92 | Dicarboxylic aciduria (HP:0003215) | 1.98903157 |
| 93 | Renal tubular dysfunction (HP:0000124) | 1.98828599 |
| 94 | Pancreatic fibrosis (HP:0100732) | 1.98811421 |
| 95 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.94808056 |
| 96 | Respiratory failure (HP:0002878) | 1.94781530 |
| 97 | Abnormal pupillary function (HP:0007686) | 1.94453199 |
| 98 | Orchitis (HP:0100796) | 1.93716293 |
| 99 | Paralysis (HP:0003470) | 1.90397733 |
| 100 | Abnormal protein glycosylation (HP:0012346) | 1.89030237 |
| 101 | Abnormal glycosylation (HP:0012345) | 1.89030237 |
| 102 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.89030237 |
| 103 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.89030237 |
| 104 | Basal ganglia calcification (HP:0002135) | 1.88822096 |
| 105 | Glomerulonephritis (HP:0000099) | 1.88664792 |
| 106 | Aplastic anemia (HP:0001915) | 1.87021517 |
| 107 | Vomiting (HP:0002013) | 1.84342270 |
| 108 | Polyphagia (HP:0002591) | 1.83532423 |
| 109 | Recurrent pneumonia (HP:0006532) | 1.83396559 |
| 110 | Exercise intolerance (HP:0003546) | 1.82168676 |
| 111 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.81454129 |
| 112 | Concave nail (HP:0001598) | 1.81419074 |
| 113 | True hermaphroditism (HP:0010459) | 1.81352855 |
| 114 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.81253731 |
| 115 | Sparse eyelashes (HP:0000653) | 1.79966066 |
| 116 | Myositis (HP:0100614) | 1.79896927 |
| 117 | Reduced antithrombin III activity (HP:0001976) | 1.78377272 |
| 118 | Amyloidosis (HP:0011034) | 1.78013501 |
| 119 | Optic neuritis (HP:0100653) | 1.77611469 |
| 120 | Retrobulbar optic neuritis (HP:0100654) | 1.77611469 |
| 121 | Steatorrhea (HP:0002570) | 1.77608281 |
| 122 | Hypokinesia (HP:0002375) | 1.77256809 |
| 123 | Joint hemorrhage (HP:0005261) | 1.77200805 |
| 124 | Hypergammaglobulinemia (HP:0010702) | 1.76729954 |
| 125 | Opisthotonus (HP:0002179) | 1.75919292 |
| 126 | Prostate neoplasm (HP:0100787) | 1.74715248 |
| 127 | Conical tooth (HP:0000698) | 1.74566830 |
| 128 | Myokymia (HP:0002411) | 1.74378622 |
| 129 | Pruritus (HP:0000989) | 1.73341705 |
| 130 | Leukodystrophy (HP:0002415) | 1.72622138 |
| 131 | Abnormal urine phosphate concentration (HP:0012599) | 1.72512742 |
| 132 | Increased serum pyruvate (HP:0003542) | 1.71391839 |
| 133 | Nephronophthisis (HP:0000090) | 1.70511469 |
| 134 | Hypothermia (HP:0002045) | 1.70393795 |
| 135 | Gliosis (HP:0002171) | 1.70224334 |
| 136 | Pustule (HP:0200039) | 1.68849608 |
| 137 | Anhidrosis (HP:0000970) | 1.68131509 |
| 138 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.67842454 |
| 139 | Increased serum lactate (HP:0002151) | 1.67661154 |
| 140 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.67346257 |
| 141 | Patchy hypopigmentation of hair (HP:0011365) | 1.66971026 |
| 142 | Tetraparesis (HP:0002273) | 1.66891123 |
| 143 | Gangrene (HP:0100758) | 1.66678261 |
| 144 | Medial flaring of the eyebrow (HP:0010747) | 1.65328074 |
| 145 | Sclerocornea (HP:0000647) | 1.57367075 |
| 146 | Rough bone trabeculation (HP:0100670) | 1.56099120 |
| 147 | Delayed CNS myelination (HP:0002188) | 1.55222450 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VRK2 | 5.34503607 |
| 2 | PBK | 4.84782816 |
| 3 | NME2 | 3.85656171 |
| 4 | MST4 | 3.49543086 |
| 5 | PIM2 | 3.46209448 |
| 6 | MAP3K14 | 3.10304467 |
| 7 | BLK | 2.82727838 |
| 8 | IRAK4 | 2.37505838 |
| 9 | IRAK3 | 2.34370433 |
| 10 | IKBKB | 2.19331569 |
| 11 | TBK1 | 2.16895913 |
| 12 | TAF1 | 1.97407565 |
| 13 | BMPR2 | 1.92482920 |
| 14 | KDR | 1.85834828 |
| 15 | RIPK4 | 1.85069918 |
| 16 | ABL2 | 1.84825025 |
| 17 | ARAF | 1.81678868 |
| 18 | TYK2 | 1.78839973 |
| 19 | TESK1 | 1.63808598 |
| 20 | IKBKE | 1.63046031 |
| 21 | MAP3K3 | 1.57057391 |
| 22 | BMPR1B | 1.53825261 |
| 23 | WNK3 | 1.51416875 |
| 24 | STK39 | 1.47905647 |
| 25 | MST1R | 1.40631198 |
| 26 | LIMK1 | 1.38491151 |
| 27 | BCR | 1.35121300 |
| 28 | TESK2 | 1.33824535 |
| 29 | MAP3K12 | 1.31126567 |
| 30 | VRK1 | 1.25780260 |
| 31 | TLK1 | 1.25241928 |
| 32 | GRK7 | 1.21622651 |
| 33 | MAP3K11 | 1.20763194 |
| 34 | STK16 | 1.20735730 |
| 35 | NEK1 | 1.19418558 |
| 36 | GRK1 | 1.15534486 |
| 37 | EPHA2 | 1.11341441 |
| 38 | ADRBK2 | 1.11309493 |
| 39 | MAP2K7 | 1.10796372 |
| 40 | MYLK | 1.07829571 |
| 41 | MAP4K2 | 1.04134215 |
| 42 | PDK2 | 1.03392812 |
| 43 | MAP2K2 | 1.01964756 |
| 44 | CSNK1G3 | 1.01219087 |
| 45 | PIM1 | 0.98541914 |
| 46 | TRIM28 | 0.95866944 |
| 47 | EPHB1 | 0.92014253 |
| 48 | ZAK | 0.91477369 |
| 49 | EIF2AK3 | 0.90991240 |
| 50 | LRRK2 | 0.90848915 |
| 51 | TIE1 | 0.89780116 |
| 52 | TXK | 0.89627619 |
| 53 | EIF2AK2 | 0.89554201 |
| 54 | BUB1 | 0.89312076 |
| 55 | TRPM7 | 0.88518379 |
| 56 | IRAK2 | 0.87789334 |
| 57 | NME1 | 0.87143623 |
| 58 | CSNK1G2 | 0.86262214 |
| 59 | TEC | 0.85930349 |
| 60 | CDK19 | 0.85901128 |
| 61 | IRAK1 | 0.85519935 |
| 62 | JAK3 | 0.84132922 |
| 63 | PLK3 | 0.82369040 |
| 64 | CDK8 | 0.81417122 |
| 65 | OXSR1 | 0.80919232 |
| 66 | DYRK2 | 0.80607790 |
| 67 | DYRK3 | 0.79699490 |
| 68 | EIF2AK1 | 0.79473482 |
| 69 | CHUK | 0.78881138 |
| 70 | PHKG2 | 0.78515247 |
| 71 | PHKG1 | 0.78515247 |
| 72 | NEK9 | 0.77826734 |
| 73 | EPHB2 | 0.77501823 |
| 74 | GRK5 | 0.76535257 |
| 75 | CSNK1G1 | 0.73876345 |
| 76 | MET | 0.72358509 |
| 77 | SRPK1 | 0.72219273 |
| 78 | LYN | 0.72046787 |
| 79 | FGR | 0.71740072 |
| 80 | KIT | 0.70614734 |
| 81 | CDC7 | 0.69490714 |
| 82 | TGFBR1 | 0.69273006 |
| 83 | AURKA | 0.68734696 |
| 84 | RPS6KA5 | 0.67953993 |
| 85 | RPS6KA4 | 0.66926620 |
| 86 | DAPK1 | 0.66553720 |
| 87 | DAPK3 | 0.65884677 |
| 88 | SYK | 0.65824061 |
| 89 | MAPK15 | 0.65717085 |
| 90 | YES1 | 0.65152975 |
| 91 | NLK | 0.65101321 |
| 92 | CCNB1 | 0.64472712 |
| 93 | PRKCD | 0.63816721 |
| 94 | CASK | 0.63096068 |
| 95 | STK4 | 0.62827362 |
| 96 | MARK3 | 0.62676790 |
| 97 | MAPKAPK5 | 0.62138719 |
| 98 | PRKCG | 0.61960840 |
| 99 | TAOK3 | 0.60801314 |
| 100 | PLK4 | 0.60635044 |
| 101 | INSRR | 0.60072130 |
| 102 | PAK4 | 0.58811133 |
| 103 | CSNK2A2 | 0.58790242 |
| 104 | PKN1 | 0.58754405 |
| 105 | WNK4 | 0.58051123 |
| 106 | MATK | 0.56961462 |
| 107 | PIK3CG | 0.56793852 |
| 108 | PRKCI | 0.56706865 |
| 109 | BTK | 0.56468455 |
| 110 | CSNK1A1L | 0.55396988 |
| 111 | DDR2 | 0.55280610 |
| 112 | TNIK | 0.55168855 |
| 113 | ADRBK1 | 0.54415596 |
| 114 | MAP2K3 | 0.53745967 |
| 115 | MAPKAPK2 | 0.53518390 |
| 116 | MAP4K1 | 0.52765544 |
| 117 | NUAK1 | 0.52712119 |
| 118 | ACVR1B | 0.52110554 |
| 119 | ILK | 0.51190493 |
| 120 | CSK | 0.51185881 |
| 121 | ERBB3 | 0.50016088 |
| 122 | MAP3K4 | 0.49362931 |
| 123 | MUSK | 0.49257786 |
| 124 | PAK3 | 0.48805101 |
| 125 | BRAF | 0.48782361 |
| 126 | RPS6KB2 | 0.47810340 |
| 127 | ERN1 | 0.47363230 |
| 128 | CLK1 | 0.46600009 |
| 129 | TGFBR2 | 0.46376047 |
| 130 | LCK | 0.46154081 |
| 131 | PRKCE | 0.44734277 |
| 132 | PNCK | 0.44437181 |
| 133 | ERBB4 | 0.44066565 |
| 134 | WEE1 | 0.44051155 |
| 135 | TAOK2 | 0.43334705 |
| 136 | MAP2K6 | 0.43257942 |
| 137 | AURKB | 0.43005022 |
| 138 | PAK1 | 0.42665440 |
| 139 | PINK1 | 0.41966877 |
| 140 | ABL1 | 0.41892101 |
| 141 | MAP3K5 | 0.41715098 |
| 142 | PLK1 | 0.41546497 |
| 143 | CSNK2A1 | 0.41417537 |
| 144 | PRKG2 | 0.40887936 |
| 145 | CAMK2G | 0.40812711 |
| 146 | ZAP70 | 0.40137523 |
| 147 | MAPKAPK3 | 0.40049570 |
| 148 | PRKCQ | 0.39484034 |
| 149 | CDK14 | 0.38814479 |
| 150 | CAMK2D | 0.38567047 |
| 151 | NEK6 | 0.38550513 |
| 152 | PLK2 | 0.38448601 |
| 153 | MOS | 0.38346531 |
| 154 | BCKDK | 0.38203842 |
| 155 | CDK11A | 0.36638248 |
| 156 | TAOK1 | 0.36012584 |
| 157 | CDK18 | 0.35647402 |
| 158 | CDK15 | 0.35092308 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 4.61979465 |
| 2 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.60099098 |
| 3 | Proteasome_Homo sapiens_hsa03050 | 3.52936727 |
| 4 | Parkinsons disease_Homo sapiens_hsa05012 | 2.72197323 |
| 5 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.56816652 |
| 6 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.51131317 |
| 7 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 2.21013732 |
| 8 | Allograft rejection_Homo sapiens_hsa05330 | 2.02770841 |
| 9 | Protein export_Homo sapiens_hsa03060 | 2.02731331 |
| 10 | Alzheimers disease_Homo sapiens_hsa05010 | 1.97944810 |
| 11 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.94873442 |
| 12 | Huntingtons disease_Homo sapiens_hsa05016 | 1.92449180 |
| 13 | RNA polymerase_Homo sapiens_hsa03020 | 1.86714239 |
| 14 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.84185639 |
| 15 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.73360154 |
| 16 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.72577774 |
| 17 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.72353901 |
| 18 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.61379384 |
| 19 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.58535543 |
| 20 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.52773893 |
| 21 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.52672980 |
| 22 | Asthma_Homo sapiens_hsa05310 | 1.46672158 |
| 23 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.43602378 |
| 24 | Histidine metabolism_Homo sapiens_hsa00340 | 1.43229636 |
| 25 | Leishmaniasis_Homo sapiens_hsa05140 | 1.40006657 |
| 26 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.39679383 |
| 27 | Pertussis_Homo sapiens_hsa05133 | 1.37273578 |
| 28 | Mismatch repair_Homo sapiens_hsa03430 | 1.35618567 |
| 29 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.31167448 |
| 30 | Legionellosis_Homo sapiens_hsa05134 | 1.30442709 |
| 31 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.30325918 |
| 32 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.28072133 |
| 33 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.21168745 |
| 34 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.21139002 |
| 35 | Phagosome_Homo sapiens_hsa04145 | 1.20976599 |
| 36 | Malaria_Homo sapiens_hsa05144 | 1.20072100 |
| 37 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.19902305 |
| 38 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.19302908 |
| 39 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.17706603 |
| 40 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.17385905 |
| 41 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.11746152 |
| 42 | DNA replication_Homo sapiens_hsa03030 | 1.10497474 |
| 43 | Retinol metabolism_Homo sapiens_hsa00830 | 1.10153870 |
| 44 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.09086544 |
| 45 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.08669703 |
| 46 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.06344194 |
| 47 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.05405164 |
| 48 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.04479304 |
| 49 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.01330155 |
| 50 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.00320548 |
| 51 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.99665211 |
| 52 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.99651541 |
| 53 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.96708627 |
| 54 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.96675835 |
| 55 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.95923915 |
| 56 | Peroxisome_Homo sapiens_hsa04146 | 0.95807313 |
| 57 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.91339993 |
| 58 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.90493877 |
| 59 | Basal transcription factors_Homo sapiens_hsa03022 | 0.88982344 |
| 60 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.88805216 |
| 61 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.88752371 |
| 62 | Other glycan degradation_Homo sapiens_hsa00511 | 0.88406116 |
| 63 | Salmonella infection_Homo sapiens_hsa05132 | 0.85734910 |
| 64 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.85644285 |
| 65 | Lysosome_Homo sapiens_hsa04142 | 0.85255247 |
| 66 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.82439818 |
| 67 | Purine metabolism_Homo sapiens_hsa00230 | 0.82024681 |
| 68 | Spliceosome_Homo sapiens_hsa03040 | 0.80554008 |
| 69 | Tuberculosis_Homo sapiens_hsa05152 | 0.80471030 |
| 70 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.79856164 |
| 71 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.77241374 |
| 72 | Base excision repair_Homo sapiens_hsa03410 | 0.76493135 |
| 73 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.74927624 |
| 74 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.73662458 |
| 75 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.73470750 |
| 76 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.73417215 |
| 77 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.73223789 |
| 78 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.72156870 |
| 79 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.71756809 |
| 80 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.68987817 |
| 81 | RNA degradation_Homo sapiens_hsa03018 | 0.67524128 |
| 82 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.66403566 |
| 83 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.66223357 |
| 84 | Measles_Homo sapiens_hsa05162 | 0.65023223 |
| 85 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.64716321 |
| 86 | Sulfur relay system_Homo sapiens_hsa04122 | 0.62736150 |
| 87 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.62542417 |
| 88 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.59326829 |
| 89 | * Mineral absorption_Homo sapiens_hsa04978 | 0.59055143 |
| 90 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.57978851 |
| 91 | Apoptosis_Homo sapiens_hsa04210 | 0.57847165 |
| 92 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.57212895 |
| 93 | Metabolic pathways_Homo sapiens_hsa01100 | 0.55169541 |
| 94 | Influenza A_Homo sapiens_hsa05164 | 0.53416927 |
| 95 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.52839257 |
| 96 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.52591909 |
| 97 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.51660728 |
| 98 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.51119847 |
| 99 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.50852785 |
| 100 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.50040145 |
| 101 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.49974025 |
| 102 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.49970237 |
| 103 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.49700164 |
| 104 | Shigellosis_Homo sapiens_hsa05131 | 0.48594711 |
| 105 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.48117173 |
| 106 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.48063988 |
| 107 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.47319307 |
| 108 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.45187769 |
| 109 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.43606781 |
| 110 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.41330344 |
| 111 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.41077367 |
| 112 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.40822585 |
| 113 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.39888470 |
| 114 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.39556611 |
| 115 | Homologous recombination_Homo sapiens_hsa03440 | 0.37175825 |
| 116 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.37045709 |
| 117 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.37027912 |
| 118 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.35902316 |
| 119 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.35579779 |
| 120 | Hepatitis C_Homo sapiens_hsa05160 | 0.34222909 |
| 121 | Prion diseases_Homo sapiens_hsa05020 | 0.33398049 |
| 122 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.33267840 |
| 123 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.33212920 |
| 124 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.32223048 |
| 125 | Phototransduction_Homo sapiens_hsa04744 | 0.31543358 |
| 126 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.31326526 |
| 127 | RNA transport_Homo sapiens_hsa03013 | 0.31119448 |
| 128 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.30967411 |
| 129 | Galactose metabolism_Homo sapiens_hsa00052 | 0.30078518 |
| 130 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.28962641 |
| 131 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.28055550 |
| 132 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.27213609 |
| 133 | Carbon metabolism_Homo sapiens_hsa01200 | 0.25255189 |
| 134 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.21664373 |
| 135 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.20333085 |

